Processing of beta-amyloid precursor protein by cathepsin D - PubMed (original) (raw)
. 1996 Dec 13;271(50):31885-93.
doi: 10.1074/jbc.271.50.31885.
Affiliations
- PMID: 8943232
- DOI: 10.1074/jbc.271.50.31885
Free article
Processing of beta-amyloid precursor protein by cathepsin D
J Higaki et al. J Biol Chem. 1996.
Free article
Abstract
The events leading to the formation of beta-amyloid (betaA4) from its precursor (betaAPP) involve proteolytic cleavages that produce the amino and carboxyl termini of betaA4. The enzyme activities responsible for these cleavages have been termed beta- and gamma-secretase, respectively, although these protease(s) have not been identified. Since betaA4 is known to possess heterogeneity at both the amino and carboxyl termini, beta- and gamma-secretases may actually be a collection of proteolytic activities or perhaps a single proteolytic enzyme with broad amino acid specificity. We investigated the role of cathepsin D in the processing of betaAPP since this enzyme has been widely proposed as a gamma-secretase candidate. Treatment of a synthetic peptide that spans the gamma-secretase site of betaAPP with human cathepsin D resulted in the cleavage of this substrate at Ala42-Thr43. A sensitive liquid chromatography/mass spectrometry technique was also developed to further investigate the ability of cathepsin D to process longer recombinant betaAPP substrates (156 and 100 amino acids of betaAPP carboxyl terminus) in vitro. The precise cathepsin D cleavage sites within these recombinant betaAPP substrates were identified using this technique. Both recombinant substrates were cleaved at the following sites: Leu49-Val50, Asp68-Ala69, Phe93-Phe94. No cleavages were observed at putative gamma-secretase sites: Val40-Ile41 or Ala42-Thr43, suggesting that cathepsin D is not gamma-secretase as defined by these betaA4 termini. Under conditions where the betaAPP156 substrate was first denatured prior to cathepsin D digestion, two additional cleavage sites near the amino terminus of betaA4, Glu-3-Val-2 and Glu3-Phe4, were observed, indicating that cathepsin D cleavage of betaAPP is influenced by the structural integrity of the substrate. Taken together, these results indicate that in vitro, cathepsin D is unlikely to function as gamma-secretase; however, the ability of this enzyme to efficiently cleave betaAPP substrates at nonamyloidogenic sites within the molecule may reflect a role in betaAPP catabolism.
Similar articles
- In vitro processing of amyloid precursor protein by cathepsin D.
Sadik G, Kaji H, Takeda K, Yamagata F, Kameoka Y, Hashimoto K, Miyanaga K, Shinoda T. Sadik G, et al. Int J Biochem Cell Biol. 1999 Nov;31(11):1327-37. doi: 10.1016/s1357-2725(99)00053-9. Int J Biochem Cell Biol. 1999. PMID: 10605825 - Candidate gamma-secretases in the generation of the carboxyl terminus of the Alzheimer's disease beta A4 amyloid: possible involvement of cathepsin D.
Evin G, Cappai R, Li QX, Culvenor JG, Small DH, Beyreuther K, Masters CL. Evin G, et al. Biochemistry. 1995 Oct 31;34(43):14185-92. doi: 10.1021/bi00043a024. Biochemistry. 1995. PMID: 7578016 - Evaluation of cathepsins D and G and EC 3.4.24.15 as candidate beta-secretase proteases using peptide and amyloid precursor protein substrates.
Brown AM, Tummolo DM, Spruyt MA, Jacobsen JS, Sonnenberg-Reines J. Brown AM, et al. J Neurochem. 1996 Jun;66(6):2436-45. doi: 10.1046/j.1471-4159.1996.66062436.x. J Neurochem. 1996. PMID: 8632167 - Genes and mechanisms involved in beta-amyloid generation and Alzheimer's disease.
Steiner H, Capell A, Leimer U, Haass C. Steiner H, et al. Eur Arch Psychiatry Clin Neurosci. 1999;249(6):266-70. doi: 10.1007/s004060050098. Eur Arch Psychiatry Clin Neurosci. 1999. PMID: 10653281 Review. - Regulation of betaAPP and PrPc cleavage by alpha-secretase: mechanistic and therapeutic perspectives.
Vincent B, Cisse MA, Sunyach C, Guillot-Sestier MV, Checler F. Vincent B, et al. Curr Alzheimer Res. 2008 Apr;5(2):202-11. doi: 10.2174/156720508783954749. Curr Alzheimer Res. 2008. PMID: 18393805 Review.
Cited by
- Removal of the glycosylphosphatidylinositol anchor from PrP(Sc) by cathepsin D does not reduce prion infectivity.
Lewis PA, Properzi F, Prodromidou K, Clarke AR, Collinge J, Jackson GS. Lewis PA, et al. Biochem J. 2006 Apr 15;395(2):443-8. doi: 10.1042/BJ20051677. Biochem J. 2006. PMID: 16441239 Free PMC article. - Blood-borne amyloid-beta dimer correlates with clinical markers of Alzheimer's disease.
Villemagne VL, Perez KA, Pike KE, Kok WM, Rowe CC, White AR, Bourgeat P, Salvado O, Bedo J, Hutton CA, Faux NG, Masters CL, Barnham KJ. Villemagne VL, et al. J Neurosci. 2010 May 5;30(18):6315-22. doi: 10.1523/JNEUROSCI.5180-09.2010. J Neurosci. 2010. PMID: 20445057 Free PMC article. - Highly specific protease-based approach for detection of porphyromonas gingivalis in diagnosis of periodontitis.
Kaman WE, Galassi F, de Soet JJ, Bizzarro S, Loos BG, Veerman EC, van Belkum A, Hays JP, Bikker FJ. Kaman WE, et al. J Clin Microbiol. 2012 Jan;50(1):104-12. doi: 10.1128/JCM.05313-11. Epub 2011 Nov 9. J Clin Microbiol. 2012. PMID: 22075590 Free PMC article. - Protein truncation as a common denominator of human neurodegenerative foldopathies.
Jadhav S, Zilka N, Novak M. Jadhav S, et al. Mol Neurobiol. 2013 Dec;48(3):516-32. doi: 10.1007/s12035-013-8440-8. Epub 2013 Mar 21. Mol Neurobiol. 2013. PMID: 23516100 Review. - A novel approach for characterization of cathepsin D protease and its effect on tau and β-amyloid proteins.
Malik M, Fenko MD, Sheikh AM, Wen G, Li X. Malik M, et al. Neurochem Res. 2011 May;36(5):754-60. doi: 10.1007/s11064-010-0395-9. Epub 2011 Jan 26. Neurochem Res. 2011. PMID: 21267651
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources